High-Yield Rheumatology: Pharmacotherpay in Rheumatoid Arthritis
Update: 2021-07-05
Description
High-yield discussion of pharmacotherapy in rheumatoid arthritis; includes choice of the drug based on the stage of disease management (Non-DMARDs, conventional DMARDs, Biological DMARDs including TNF-inhibitors & non-TNF inhibitors);
The understanding of the medication choice, their side effects and pretreatment or follow up assessment is essential for many other rheumatology chapters in internal medicine & pediatrics (including seronegative spondyloarhtropathies, vasculitis arthritis, Juvenile Idiopathic Arthritis)
The understanding of the medication choice, their side effects and pretreatment or follow up assessment is essential for many other rheumatology chapters in internal medicine & pediatrics (including seronegative spondyloarhtropathies, vasculitis arthritis, Juvenile Idiopathic Arthritis)
Comments
In Channel





